• 제목/요약/키워드: LCAT

검색결과 23건 처리시간 0.023초

당뇨성 흰쥐의 과산화지질 및 Creatine Phosphokinase 활성에 돌복숭아(Prunus persica Batsch var. davidiana Max ) 열수 추출액이 미치는 영향 (The Effect of Prunus persica Batch var. davidiana Max. Hot-Water Extract on the Lipid Peroxide and Creatine Phosphokinase Activity in Streptozotocin-Induced Diabetic Rats)

  • 김한수
    • 한국식품영양학회지
    • /
    • 제18권3호
    • /
    • pp.272-278
    • /
    • 2005
  • 돌복숭아(Prunus persica Batsch var. davidiana Max.)의 생리활성 추출물질($5.0g\%$ extract)이 streptozotocin (STZ, 55mg/kg B.W., I.P. injection)으로 유발된 당뇨성 Sprague Dawley계 수컷 흰쥐의 지질 및 당질대사 이상에 의해 야기되는 각종 질환의 예방과 개선 효과 등에 많은 생리적 효능이 있을 것으로 판단되어 본 실험을 수행하였다. 기본 식이에 물 급여군인 대조군(BW군)을 비롯한 STZ 당뇨 유발 흰쥐에 물 급여군(BSW군)과 당뇨 유발군에 돌복숭아 추출액을 급여한 군(BSP군)을5주간실험 사육하였다. 혈청 중의 전해질 농도(Na, K, Cl)는 당뇨 유발군(BSW군)에 돌복숭아 추출액을 급여(BSP군)하므로서 농도가 다소 나마 감소되는 것으로 나타났지만 유의성 있는 농도의 차이는 없었다. 한편 혈청 유리지방산 및 과산화지질 농도, creatine phosphokinase활성 등에서 돌복숭아추출액을 급여하므로서 유의적인 농도와 활성 감소를 나타내었고, 혈청 lecithin cholesterol acyltransferase(LCAT) 활성은 당뇨 유발군에 돌복숭아 추출액 급여에 의하여 상승되는 것으로 나타났다. 따라서 돌복숭아 중의 생리활성물질이 STZ으로 유발된 당뇨성 흰쥐의 당질 및 지질대사 이상 등에서 오는 각종 질환의 예방 및 치료에 개선 효과가 있을 것으로 생각된다.

어유 및 종자유의 급이가 흰쥐의 혈청 지질 성분에 미치는 영향 (Effects of Fish Oil and Some Seed Oils on Lipid Composition of Serum in Rats)

  • 정효숙;김성희;김한수;김갑순;정승용
    • 한국식품영양과학회지
    • /
    • 제20권4호
    • /
    • pp.312-319
    • /
    • 1991
  • n-3계 EPA 및 DHA를 함유하고 있는 어유 및 $\alpha$- linoleic acid 함량이 많은 들깨유와 n-6계 linoleic acid 의 함량이 많은 옥수수유 및 고추종자유, n-6계 inoleic acid 함량이 많고 ${\gamma}$-linoleic acid를 약 10% 함유한 달맞이꽃종자유가 흰쥐의 혈청 지질 개선에 미치는 영향을 알아보기 위해 혈청 지질 성분을 분석한 결과, 총콜레스테롤 농도는 어유, 들깨유, 옥수수유 급여군이 대조군인 올리브유 급여군 보다 낮은 반면 고추종 자유, 달맞이꽃종자유 급여군에서 높았다. HDL-콜레스테롤 농도는 고추종자유, 달맞이꽃종자유 급여군에서 약간 높게 나타났다. 총콜레스테롤에 대한 HDL-콜레스테롤 농도비는 전 실험군에서 대조군보다 높았다. 유리콜레스테롤은 고추종자유 급여군을 제외한 전 실험군에서 대조군에 비하여 유의성있게 낮았으며 특히 어유, 들깨유 및 옥수수유 급여군에서 더욱 낮게 나타났다. 콜레스테롤 에스테르 농도는 n-6계 다불포화지방산 함량이 많은 고추종자유, 달맞이꽃종자유 군에서 높았다. 총콜레스테롤에 대한 콜레스테롤 에스테르 농도비는 대조군인 올리브유 급여군(62%)보다 전 실험군(70.0%~74.4%)에서 높게 나타났다. 인지질 농도는 어유 및 들깨유 급여군에서 낮았고, 중성지질 농도는 대조군에 비해 들깨유, 어유, 달맞이꽃종자유 군에서 현저히 낮았다. LCAT 활성은 대조군보다 돈지 급여군에서 높은 반면, 다른 실험군에서는 낮게 나타났다.

  • PDF

Effect of Ginkgo biloba Extract (EGb 761) on Serum Cholesterol Levels in Wild-type C57Bl/6 Mice

  • Hong, Jin Sung;Kim, Jin Woo;Yoon, Byung Il;Rhee, Ki-Jong;Rha, Chang Six;Jung, Bae Dong
    • 대한의생명과학회지
    • /
    • 제23권2호
    • /
    • pp.80-88
    • /
    • 2017
  • Ginkgo biloba extract (EGb 761) is a standardized extract of Ginkgo biloba leaves and has anti- atherosclerosis properties. Many patients with atherosclerosis disorders take Ginkgo biloba extracts to supplement current therapy. In addition, normal healthy individuals also take Ginkgo biloba extracts for prophylactic purposes. However, it is unknown whether supplementation of Gingko biloba extracts in healthy individuals offer a benefit. In this study, we assessed whether EGb 761 could provide beneficial effects on serum cholesterol levels in normal mice. Wild-type C56Bl/6 mice were orally administered EGb 761 at 25 mg/kg (Group 3) or 50 mg/kg (Group 4) every other day for 40 days. We found that the serum levels of HDL-cholesterol (HDL-C) were significantly increased in EGb 761 and lovastatin treated groups. Treatment with EGb 761 and lovastatin resulted in reduced serum total cholesterol and LDL-cholesterol (LDL-C) compared to control group. Serum lecithin cholesterol acyltransferase (LCAT) levels were higher in EGb 761 and lovastatin treated group compared to the control group. However, no difference was observed in serum APO A-I levels between the control group and treatment group. These results suggest that EGb 761 can increase HDL-C resulting in increased serum LCAT levels.

Corn silk extract improves cholesterol metabolism in C57BL/6J mouse fed high-fat diets

  • Cha, Jae Hoon;Kim, Sun Rim;Kang, Hyun Joong;Kim, Myung Hwan;Ha, Ae Wha;Kim, Woo Kyoung
    • Nutrition Research and Practice
    • /
    • 제10권5호
    • /
    • pp.501-506
    • /
    • 2016
  • BACKGROUNG/OBJECTIVES: Corn silk (CS) extract contains large amounts of maysin, which is a major flavonoid in CS. However, studies regarding the effect of CS extract on cholesterol metabolism is limited. Therefore, the purpose of this study was to determine the effect of CS extract on cholesterol metabolism in C57BL/6J mouse fed high-fat diets. MATERIALS/METHODS: Normal-fat group fed 7% fat diet, high-fat (HF) group fed 25% fat diet, and high-fat with corn silk (HFCS) group were orally administered CS extract (100 mg/kg body weight) daily. Serum and hepatic levels of total lipids, triglycerides, and total cholesterol as well as serum free fatty acid, glucose, and insulin levels were determined. The mRNA expression levels of acyl-CoA: cholesterol acyltransferase (ACAT), cholesterol 7-alpha hydroxylase (CYP7A1), farnesoid X receptor (FXR), lecithin cholesterol acyltransferase (LCAT), low-density lipoprotein receptor, 3-hyroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), adiponectin, leptin, and tumor necrosis factor ${\alpha}$ were determined. RESULTS: Oral administration of CS extract with HF improved serum glucose and insulin levels as well as attenuated HF-induced fatty liver. CS extracts significantly elevated mRNA expression levels of adipocytokines and reduced mRNA expression levels of HMG-CoA reductase, ACAT, and FXR. The mRNA expression levels of CYP7A1 and LCAT between the HF group and HFCS group were not statistically different. CONCLUSIONS: CS extract supplementation with a high-fat diet improves levels of adipocytokine secretion and glucose homeostasis. CS extract is also effective in decreasing the regulatory pool of hepatic cholesterol, in line with decreased blood and hepatic levels of cholesterol though modulation of mRNA expression levels of HMG-CoA reductase, ACAT, and FXR.

Synthesis of Reconstituted High Density Lipoprotein (rHDL) Containing apoA-I and apoC-III: the Functional Role of apoC-III in rHDL

  • Cho, Kyung-Hyun
    • Molecules and Cells
    • /
    • 제27권3호
    • /
    • pp.291-297
    • /
    • 2009
  • Apolipoprotein (apo) C-III is a marker protein of triacylglycerol (TG)-rich lipoproteins and high-density lipoproteins (HDL), and has been proposed as a risk factor of coronary heart disease. To compare the physiologic role of reconstituted HDL (rHDL) with or without apoC-III, we synthesized rHDL with molar ratios of apoA-I:apoC-III of 1:0, 1:0.5, 1:1, and 1:2. Increasing the apoC-III content in rHDL produced smaller rHDL particles with a lower number of apoA-I molecules. Furthermore, increasing the molar ratio of apoC-III in rHDL enhanced the surfactant-like properties and the ability to lyse dimyristoyl phosphatidylcholine. Furthermore, rHDL containing apoC-III was found to be more resistant to particle rearrangement in the presence of low-density lipoprotein (LDL) than rHDL that contained apoA-I alone. In addition, the lecithin:cholesterol acyltransferase (LCAT) activation ability was reduced as the apoC-III content of the rHDL increased; however, the CE transfer ability was not decreased by the increase of apoC-III. Finally, rHDL containing apoC-III aggravated the production of MDA in cell culture media, which led to increased cellular uptake of LDL. Thus, the addition of apoC-III to rHDL induced changes in the structural and functional properties of the rHDL, especially in particle size and rearrangement and LCAT activation. These alterations may lead to beneficial functions of HDL, which is involved in anti-atherogenic properties in the circulation.

Experimental Study on the Effects of GamiSamgieum (SGMX) on Hyperlipidemia

  • Kim, Hun;An, Joung-Jo;Jo, Hyun-Kyung;Yoo, Ho-Rhyong;Seol, In-Chan;Kim, Yoon-Sik
    • 대한한의학회지
    • /
    • 제30권3호
    • /
    • pp.86-97
    • /
    • 2009
  • Objectives : This study was aimed to investigate the effects of GamiSamgieum (SGMX) on hyperlipidemia using an animal model. Additionally, the underlying mechanisms were investigated by determination of gene expressions related with lipid metabolism. Methods : Forty mice were selected for use in this experiment, and then divided into five groups; Naive, Induced, SGMX 100, SGMX 200, and Lovastatin group as positive control with 8 mice each, and their blood was collected for analysis of blood and serum parameters. Results : Administration of SGMX significantly inhibited the increase of liver weight and the macrovacuolar cytoplasmic alterations in histopathologic finding. SGMX administration significantly protected the liver from pathologic elevation of AST and ALT and from lipid peroxidation. SGMX administration significantly lowered total cholesterol levels and TG, and partially upregulated the gene expression of LCAT, CYP7A1 and LDL-R receptor. Conclusion : SGMX is suggested to possess hypolipidemic effect, and thus could be a potential candidate for herbal hypolipidemic via further studies.

  • PDF

귀전우(鬼箭羽)(Euonymus alatus(Thunb.) Sieb)가 간암세포(肝癌細胞)(Hep3B)와 자궁암세포(子宮癌細胞)(HeLa)의 성장억제(成長抑制)에 미치는 영향(影響)에 관한 연구(硏究) (Effect of Growth Inhibition in Hep3B cell and HeLa cell by treatment of Euonymus alatus(Thunb.) Sieb extracts)

  • 최달영
    • 동국한의학연구소논문집
    • /
    • 제7권2호
    • /
    • pp.155-162
    • /
    • 1999
  • 귀전우(Euonymus alatus Sieb.)가 간암, 식도암, 위암, 자궁암등의 각종 암을 치료하는 방법으로 민방에서 많이 사용하고 있다. 실제 Euonymus alatus(Thumb.) Sieb의 추출물중 Eupolyphaga simensis(ES)는 HDL-C/TC ratio와 LCATactivity를 증진시킨다. Human hepatoblastoma 세포인 Hep3B 세포의 성장억제를 유도하는 factor로는 TGF-${\beta}$, Insulin 등으로 알려져 있다. 따라서 귀전우는 간에 있어 당 대사에 관여하는 plasma HDL3-C level은 낮게 유지함으로써 간에서 지방간 이행을 억제 하여 간에서의 암 발생을 억제하는 효과를 보인다. 실험에서 귀전우가 자궁암세포보다도 간암세포에 보다 높은 세포독성을 보임으로써 여러종류의 암에 모두 적용하기는 어렵다고 보여진다. 또한 귀전우가 바이러스에 의해 유도되는 간암과 hepatocellular Carcinoma 세포에서 효과가 있는지와 HCC에서 세포의 증식억제효과를 어떤 경로를 통해 이루어지는지 계속적으로 연구가 수행되어져야 될 것이다.

  • PDF

고지방 식이 마우스에서 석창포 열수 추출물의 혈중지질 개선 효과 (Effect of Acorus gramineus Water Extract on the Blood Lipid Profiles in High Fat Diet-fed Mice)

  • 홍선화;김동우;최연식;김다슬;김옥진
    • 한국자원식물학회지
    • /
    • 제29권4호
    • /
    • pp.355-362
    • /
    • 2016
  • 혈중 LDL 콜레스테롤 농도는 이상 lipoprotein metabolism의 유효한 지표로 간주되고 있으며, 관상동맥질환 및 동맥경화증의 위해성과 직접 연관이 있는 것으로 알려져 있다(Goldstein and Brown, 1983; Venter et al., 1990). 또한 HDL 콜레스테롤은 말초조직에서 간으로의 콜레스테롤의 이동에서 중요한 역할을 하며, 유리형 콜레스테롤의 에스테르화를 촉매하는 효소인 lecithin:cholesterol acetyltransferase (LCAT)를 활성화하여 세포 안으로 콜레스테롤의 유입을 억제함으로써 동맥경화를 막는 역할을 한다(Steinberg and Witztum, 1990). 본 연구 결과 석창포 열수 추출물은 혈중 triglyceride 수준을 유의하게 낮추는 효과가 입증되었다. 또한 석창포 열수 추출물은 혈중 total cholesterol과 HDL-cholesterol 수준을 WKAG-M, WKAG-H군에서 유의하게 감소 시켰으며 LDL-cholesterol 수준은 석창포 열수 추출물 투여에 의해 유의적으로 증가되었다. 또한 이러한 결과로부터 석창포 열수 추출물은 혈중 지질 조절에 의해 동맥 경화 지수를 감소시킬 수 있으며 심장 위험 지수 또한 감소시킬 수 있음을 알 수 있었다. 추후 석창포 열수 추출물 분획 중의 각 성분들이 혈중 지질 성상에 미치는 효과를 규명하는 연구를 수행하여 유효성분에 대한 연구를 계속할 예정이다.

Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity

  • Yoo, Jeong-Ah;Lee, Eun-Young;Park, Ji Yoon;Lee, Seung-Taek;Ham, Sihyun;Cho, Kyung-Hyun
    • Molecules and Cells
    • /
    • 제38권6호
    • /
    • pp.573-579
    • /
    • 2015
  • Apolipoprotein A-I and A-IV are protein constituents of high-density lipoproteins although their functional difference in lipoprotein metabolism is still unclear. To compare anti-atherogenic properties between apoA-I and apoA-4, we characterized both proteins in lipid-free and lipidbound state. In lipid-free state, apoA4 showed two distinct bands, around 78 and $67{\AA}$ on native gel electrophoresis, while apoA-I showed scattered band pattern less than $71{\AA}$. In reconstituted HDL (rHDL) state, apoA-4 showed three major bands around $101{\AA}$ and $113{\AA}$, while apoA-I-rHDL showed almost single band around $98{\AA}$ size. Lipid-free apoA-I showed 2.9-fold higher phospholipid binding ability than apoA-4. In lipid-free state, $BS_3$-crosslinking revealed that apoA-4 showed less multimerization tendency upto dimer, while apoA-I showed pentamerization. In rHDL state (95:1), apoA-4 was existed as dimer as like as apoA-I. With higher phospholipid content (255:1), five apoA-I and three apoA-4 were required to the bigger rHDL formation. Regardless of particle size, apoA-I-rHDL showed superior LCAT activation ability than apoA-4-rHDL. Uptake of acetylated LDL was inhibited by apoA-I in both lipid-free and lipid-bound state, while apoA-4 inhibited it only lipid-free state. ApoA-4 showed less anti-atherogenic activity with more sensitivity to glycation. In conclusion, apoA-4 showed inferior physiological functions in lipid-bound state, compared with those of apoA-I, to induce more pro-atherosclerotic properties.

Effect of conjugated linoleic acid in diacylglycerol-rich oil on the lipid metabolism of C57BL/6J mice fed a high-fat high-cholesterol diet

  • Lee, Jeung Hee;Cho, Kyung-Hyun;Lee, Ki-Teak
    • 농업과학연구
    • /
    • 제41권1호
    • /
    • pp.47-58
    • /
    • 2014
  • The effect of conjugated linoleic acid (CLA) isomers esterified in diacylglycerol (DAG)-rich oil on lipid metabolism was investigated. Since dietary DAG has been known to induce the regression of atherosclerosis, CLA-DAG and olive-DAG oils containing similar levels of DAG (51.4~54.2%) were synthesized from olive oil. Hyperlipidemic C57BL/6J mice were then fed high-fat high-cholesterol diets supplemented with these oils (5% each) for 7 wk. The CLA-DAG diet containing 2.1% CLA isomers (0.78% c9,t11-CLA; 1.18% t10,c12-CLA) remarkably increased the levels of total plasma cholesterol and glutamic oxaloacetic transaminase (GOT) along with hepatic cholesterol and triacylglycerol (TAG) contents. Furthermore, the CLA-DAG diet inhibited fat uptake into adipose tissue whereas fat deposition (especially in the liver) was increased, resulting in the development of fatty livers. Hepatic fatty acid composition in the CLA-DAG mice was different from that of the olive-DAG mice, showing higher ratios of C16:1/C16:0 and C18:1/C18:0 in the liver. The activity of hepatic acyl-CoA:cholesterol acyltransferase (ACAT) was higher in CLA-DAG mice while plasma lecithin:cholesterol acyltransferase (LCAT) activity and the ferric reducing ability of plasma (FRAP) were lower in CLA-DAG mice compared to the olive-DAG animals. Results of the present study suggest that CLA incorporation into DAG oil could induce atherosclerosis in mice.